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Glutathione carries out vital protective roles within mitochondria, but is synthesised in the cytosol.
Previous studies have suggested that the mitochondrial dicarboxylate and 2-oxoglutarate carriers
were responsible for glutathione uptake. We set out to characterise the putative glutathione trans-
port by using fused membrane vesicles of Lactococcus lactis overexpressing the dicarboxylate and
2-oxoglutarate carriers. Although transport of the canonical substrates could be measured readily,
an excess of glutathione did not compete for substrate uptake nor could transport of glutathione be
measured directly. Thus these mitochondrial carriers do not transport glutathione and the identity
of the mitochondrial glutathione transporter remains unknown.
 2015 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical
Societies. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Mitochondria are dynamic subcellular organelles that rely on
the import of nuclear-encoded proteins and the transport of
metabolites and essential cofactors across the relatively imperme-
able inner membrane [1]. Dysfunctional mitochondrial transport is
linked to a range of human pathologies [2,3]. Glutathione (GSH) is
an essential small peptide present throughout the cell that has
vital protective roles within mitochondria [4,5]. The mitochondrial
GSH concentration is 1–5 mM and this pool exists predominantly
(95–99%) in the reduced form due to NADPH-dependent glutathi-
one reductase, whereas the remainder is in the oxidised glutathi-
one disulphide (GSSG) form [5–7]. GSH protects against damage
by degrading peroxides, detoxifying electrophiles and by interact-
ing with protein thiols to prevent oxidative damage and mediate
redox signalling (Fig. 1A) [5]. These roles are particularly vital inmitochondria, as GSH depletion within the organelle greatly
increases oxidative damage, leading to cell dysfunction and death
[8]. Thus the mitochondrial GSH pool plays a key role in preventing
pathologies, such as neurological disorders, ischaemia/reperfusion
injury and alcoholic liver disease [4,9,10].
GSH is exclusively made in the cytosol by c-glutamylcysteine
synthetase and glutathione synthetase (Fig. 1A) [11], and therefore
its transport across the mitochondrial inner membrane is required
[6]. Previous studies have suggested that mitochondrial GSH trans-
port was carried out by two members of the mitochondrial carrier
family (SLC25), the mitochondrial dicarboxylate carrier (DIC;
SLC25A10) and the 2-oxoglutarate carrier (OGC; SLC25A11) [12–
19]. In mammals the mitochondrial carrier family consists of 53
members, about half of which have been functionally characterised
[2]. All family members have six transmembrane helices, N and C
termini that protrude into the intermembrane space (Fig. 1A) and
a tripartite sequence repeat of about 100 amino acids [20]. The
overall structural fold of the carriers consist of six transmembrane
a-helices arranged in a threefold pseudo-symmetrical way
[21–23]. There are two sets of salt bridges on the matrix and cyto-
plasmic side of the carriers that regulate access to a central sub-
strate-binding site for the exchange of metabolites across the
mitochondrial inner membrane [24]. The mitochondrial carrier
family transports many anion metabolites, such as citrate, malate,
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didates for the import of GSH (Fig. 1B).
Early studies reported mitochondrial GSH transport in isolated
rat liver mitochondria through both high afﬁnity (Km = 60 lM,
Vmax = 0.5 nmol min1 mg protein1) and low afﬁnity transport
systems (Km = 5.4 mM, Vmax = 5.9 nmol min1 mg protein1)
[25,26] that required a proton motive force. Subsequent studies
have suggested that DIC and OGC were involved in mitochondrial
glutathione transport. These studies used a variety of systems, such
as Xenopus laevis oocytes [27], isolated kidney mitochondria and
mitoplasts [13,14], and reconstituted proteoliposomes [16], but
the GSH transport activity of these carriers was not fully explored.
Therefore, we set out to characterise in detail the GSH transport
capabilities of the DIC and OGC by using the well-established Lacto-
coccus lactis system for overexpression and characterisation of
members of the mitochondrial carrier family [28,29].
The OGC and DIC carriers were overexpressed in the cytoplas-
mic membrane of L. lactis. Isolated membrane vesicles were fused
with liposomes and loaded with substrate to measure the
exchange with radiolabelled metabolites [21]. Both OGC and DIC
transported their canonical substrates, 2-oxoglutarate/malate and
phosphate/malate, respectively. Surprisingly however, substrate
competition assays with excess GSH had no effect on the transport
rate in contrast to known substrates or inhibitors. Furthermore,
there was no detectable transport of [35S]-GSH by these carriers.
Together these data demonstrate that DIC and OGC do not trans-
port GSH.
2. Materials and methods
2.1. Materials
All materials were from Sigma–Aldrich, unless otherwise stated.
M17 media (ForMedium) contained 5% (w/v) pancreatic digest of
casein, 5% (w/v) soy peptone, 5% (w/v) beef extract, 2.5% (w/v)
yeast extract, 0.5% (w/v) ascorbic acid, 0.25% (w/v) magnesium sul-
phate, 19% (w/v) disodium-b-glycerophosphate. SM17 plates con-
sisted of M17 broth supplemented with 0.5 M sucrose and 1.5%
(w/v) agar. Radiochemicals were from American Radiolabelled
Chemicals and Perkin Elmer. Primers were from Sigma–Aldrich.
2.2. Molecular cloning
Codon-optimised genes for OGC (Homo sapiens; Uniprot ID:
Q02978), DIC (H. sapiens; Uniprot ID: Q9UBX3, Saccharomyces cere-
visiae; Uniprot ID: Q06143), CiC (H. sapiens, Uniprot ID: P53007)
and AAC (Myceliophthora thermophila: Uniprot ID: G2QNH0) were
synthesised by GenScript. For expression in L. lactis, the genes were
cloned into the expression vector pNZ8048 and transformed into
the electrocompetent L. lactis strain NZ9000. Successful transfor-
mants were selected on SM17 plates containing 5 lg mL1 chlor-
amphenicol, and conﬁrmed by DNA sequencing.
2.3. Cell growth and membrane isolation
Pre-cultures of L. lactis were obtained by inoculating M17 med-
ium supplemented with 1% (w/v) glucose and 5 lg mL1 chloram-
phenicol from glycerol stocks and incubating the cultures
overnight at 30 C with no aeration. The OD600 was measured
and cells diluted to a starting OD600 of 0.1 in fresh M17 medium
supplemented with 1% (w/v) glucose and 5 lg mL1 chloramphen-
icol. Cells were grown at 30 C with no aeration until the OD600
reached 0.5. The expression of the recombinant proteins was
induced by addition of nisin A with a dilution of 1:10000 of spent
M17 medium from the nisin A secreting L. lactis strain NZ9700.
The cells were grown for a further 2 h at 30 C, harvested bycentrifugation (6000g, 10 min, 4 C), resuspended in Tris-buf-
fered saline, pH 7.4 (TBS) and collected by centrifugation as before.
The cells were resuspended in TBS buffer and disrupted mechani-
cally with a cell disruptor (Constant Cell Disruption Systems) at
33000 psi. Whole cells and debris were removed by centrifugation
(10800g, 15 min, 4 C), and membranes were collected by ultra-
centrifugation (138000g, 1 h, 4 C). Pellets were resuspended in
TBS buffer to a total protein concentration of approximately
5 mg mL1 and stored in liquid nitrogen.
2.4. Fusion of membrane vesicles and liposomes
Escherichia coli polar lipid extract and egg yolk phosphatidyl-
choline (Avanti Polar Lipids) were mixed in a weight ratio of 3:1.
The lipids were resuspended in TBS buffer to a ﬁnal concentration
of 20 mg mL1 and frozen in liquid nitrogen. For membrane
fusions, 1 mg L. lactis membranes were mixed with 5 mg lipo-
somes, diluted to a ﬁnal volume of 900 lL with TBS, and fused by
seven cycles of freezing in liquid nitrogen and thawing at room
temperature before storage in liquid nitrogen. The membrane ves-
icle fusions were thawed, and internal substrate added to a ﬁnal
concentration of 5 mM. Vesicles were extruded 11 times through
a 1 mm pore size polycarbonate ﬁlter, passed through a pre-equili-
brated PD10 column (GE Healthcare) to remove external substrate,
and collected in 1.6 mL TBS buffer.
2.5. Transport assays
Transport assays were carried out using a Hamilton MicroLab
Star robot (Hamilton Robotics Ltd.). Transport of radiolabeled sub-
strate was initiated by the addition of 100 lL TBS buffer with
1.5 lM [14C]-malate (2.22 GBq mmol1) or 1.5 lM [35S]-GSH
(16.946 TBq mmol1) to 5 lg fused membranes in a Multi-
ScreenHTS-HA 96-well ﬁlter plate (pore size = 0.45 mm Millipore).
The transport was stopped at 0, 10, 20, 30, 45 s, 1, 2.5, 5, 7.5, 10
and 15 min by the addition of 200 lL ice-cold TBS buffer and ﬁlter-
ing using a vacuum manifold, followed by an additional wash step
with 200 lL ice-cold TBS buffer. Levels of radioactivity in the
vesicles were measured by the addition of 200 lL MicroScint-20
(Perkin Elmer) and by quantifying the amount of radioactivity with
the TopCount scintillation counter (Perkin Elmer). Initial rates
were determined from the linear part of the uptake curves. Exter-
nal compounds were added at a ﬁnal concentration of 10 mM, with
the exception of NEM, which was added at 1 mM.
2.6. SDS–PAGE and immunoblotting
To assess protein expression, 10 lg L. lactis membranes were
loaded onto 12% Mini-Protean Precast Tris–Glycine gels (BioRad)
and run at 120 V. Gels were stained in Imperial Protein Stain
(Thermo Scientiﬁc). Immunoblotting was carried out after semi-
dry transfer of SDS–PAGE gels onto PVDF membrane. Membranes
were incubated in 3% milk containing 1:10000 primary rabbit
anti-OGC antibody for 1 h at RT. After washing, membranes were
incubated in 1:10000 goat anti-rabbit secondary antibody conju-
gated to horse radish peroxidase for 1 h at RT. Antibody-labelled
proteins were detected using the ECL reagent Western blot detec-
tion kit (GE Healthcare), following the instructions of the manufac-
turer, and visualised by developing the exposed ﬁlm.
2.7. N-terminal modiﬁcation by PCR
Primers corresponding to N-terminal regions of mitochondrial
carriers known to express in L. lactis were designed. Extension
PCR was performed using KOD Hot Start DNA Polymerase kit
(Merck Millipore) on the human DIC pUC57 plasmid from
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Fig. 1. (A) GSH is synthesised in the cytoplasm and transported into the mitochondria where it is involved in protective processes. The dicarboxylate carrier (DIC), left, and
the 2-oxoglutarate carrier (OGC), right, are shown transporting their canonical substrates. GSH is involved in the protection against lipid peroxidation, hydrogen peroxide, and
protein thiol oxidation. (B) Chemical structures of DIC/OGC substrates along with GSH and GSSG. (C) Expression of DIC and OGC in L. lactismembranes. Bands at 32 kDa can
be observed on SDS–PAGE gels stained with Coomassie. Immunoblotting against human OGC highlighted a speciﬁc band in the membrane fraction, but no antibody was
available to probe S. cerevisiae DIC. (D) Alignments of the transmembrane a-helices 2, 4 and 6 from S. cerevisiae DIC and Homo sapiens DIC. Residues involved in substrate
binding are highlighted in red [34–36].
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N-terminus of mitochondrial carriers can improve their expression
levels and activity [28]. To achieve this, primers corresponding to
N-terminal truncations were designed for the AAC and CiC carriers
(D amino acid residues 2–19 and D amino acid residues 2–20, for
AAC and CiC, respectively). PCR was carried out on the pUC57 plas-
mid containing AAC or CiC. Altered genes were then cloned into L.
lactis as previously described.
2.8. Statistics
Statistical tests were undertaken in Prism (GraphPad). ANOVAs
with post-Bonferroni tests were performed on initial rate data totest for differences. All other statistical analyses were performed
using Student’s t-test with details given in the ﬁgure legends.
3. Results and discussion
3.1. Expression of OGC and DIC
Genes encoding human OGC and DIC were cloned into expres-
sion vector pNZ8048 and transformed into L. lactis. A control strain
was made by transforming L. lactis with pNZ8048 lacking a trans-
porter gene. Expression of OGC could be observed in membranes
separated by SDS–PAGE and was conﬁrmed by Western blotting
(Fig. 1C). In contrast, expression of human DIC was very low (data
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Fig. 2. OGC-mediated transport of its canonical substrates is unaffected by excess GSH. (A) Malate/2-oxoglutarate hetero-exchange in the absence and presence of excess 2-
oxoglutarate and GSH. Fused membranes expressing OGC were pre-loaded with 5 mM 2-oxoglutarate and incubated with 1.5 lM [14C]-malate for 15 min, after which
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624 L.M. Booty et al. / FEBS Letters 589 (2015) 621–628not shown) and transport activity for its canonical substrate
malate, measured as malate/[14C]-malate exchange, was negligible
(Fig. S1). As the N-terminal region is critical for successful expres-
sion and protein folding of mitochondrial carriers in L. lactis [28],
N-termini from three mitochondrial carrier proteins that are well
expressed in L. lactis were added to the N-terminal terminus of
human DIC by extension PCR, and the resultant gene was cloned
and expressed in L. lactis. However, none of the modiﬁed genes
showed signiﬁcant expression (data not shown) or [14C]-malate/malate exchange in malate-loaded vesicles (Fig. S1). Therefore,
we focussed on the Saccharomyces cerevisiae DIC [31], which is
40% identical to human DIC, with high sequence similarity in
the functionally important salt bridge networks and substrate
binding site [24] (Fig. 1D). In yeast, GSH is also made exclusively
in the cytosol and then transported into mitochondria [30]. There-
fore, S. cerevisiae DIC could be used to assess whether the mito-
chondrial dicarboxylate carrier can transport GSH. The gene
coding for S. cerevisiae DIC was cloned into pNZ8048 and
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L.M. Booty et al. / FEBS Letters 589 (2015) 621–628 625transformed into L. lactis. S. cerevisiae DIC was expressed in the
cytoplasmic membrane (Fig. 1C) and was able to transport its
canonical substrates.
3.2. Metabolite transport assays
To determine the transport activity and substrate speciﬁcity of
the OGC, L. lactis membranes containing OGC were fused with lip-
osomes preloaded with 5 mM internal substrate (2-oxoglutarate or
malate) and transport was initiated with 1.5 lM [14C]-malate
(Fig. 2A and C). Heteroexchange of 2-oxoglutarate for [14C]-malatewas quenched by excess of unlabelled 2-oxoglutarate added exter-
nally, whereas addition of excess GSH had no effect on transport
(Fig. 2A). Transport experiments were carried out in the presence
or absence of external substrates and inhibitors [32] and the
results showed that the initial transport rate was quenched by
excess 2-oxoglutarate or malate and by known OGC inhibitors phe-
nylsuccinate and N-ethylmaleimide (NEM), whereas GSH had no
effect. Excess glutamate had a minor competitive effect on trans-
port (Fig. 2B). Together these data show that GSH is not a compet-
itive substrate of OGC. Addition of supraphysiological excess of
GSSG had a small effect on [14C]-malate uptake, but this is likely
050
100
150
In
 / 
O
ut
Em
pt
y 
/ G
SH
M
al
at
e 
/ M
al
at
e
O
xo
gl
ut
ar
at
e 
/ M
al
at
e
G
SH
 / 
G
SH
Em
pt
y 
/ G
SH
M
al
at
e 
/ M
al
at
e
O
xo
gl
ut
ar
at
e 
/ M
al
at
e
G
SH
 / 
G
SH
Em
pt
y 
/ G
SH
M
al
at
e 
/ M
al
at
e
Ph
os
ph
at
e 
/ M
al
at
e
G
SH
 / 
G
SH
O
xo
gl
ut
ar
at
e 
/ G
SH
Ph
os
ph
at
e 
/ G
SH
***
***
***
***
Empty
OGC
DIC
In
iti
al
 ra
te
 o
f u
pt
ak
e
 (p
m
ol
 m
g-
1  p
ro
te
in
 m
in
-1
)
Out
In
A
B [35S]-GSH
GSH
G
SS
G
 / 
M
al
at
e
G
SS
G
 / 
M
al
at
e
G
SS
G
 / 
M
al
at
e
DIC
OGC
Empty
In
iti
al
 ra
te
 o
f [
35
S]
-G
SH
 u
pt
ak
e
 (p
m
ol
 m
g-
1  p
ro
te
in
 m
in
-1
)
0
50
100
150
pH 6 pH 8pH 7
Fig. 4. DIC or OGC do not transport GSH (A) [35S]-GSH uptake by fused membranes of the control (white bars), OGC-expressing (grey bars) and DIC-expressing (black bars)
strains. The fused membranes were internally loaded with 5 mM of the indicated substrates (in) and incubated with 1.5 lM of the indicated external radio-labelled substrate
(out) for 15 min. The initial exchange rates were determined over the ﬁrst 60 s. (B) [35S]-GSH uptake at different pH values. Fused membranes of the control (white bar), OGC-
expressing (grey bars) and DIC-expressing (black bars) strains were preloaded with 5 mMGSH and incubated with 1.5 lM [35S]-GSH to initiate exchange. The initial exchange
rates were determined in the ﬁrst 60 s time interval. Data are represented by the mean ± S.D. (n = 4). ⁄⁄⁄P < 0.001 for comparison of transport of radiolabelled substrate by
control vesicles against OGC/DIC vesicles by ANOVA.
626 L.M. Booty et al. / FEBS Letters 589 (2015) 621–628to be due to reaction of GSSG with available protein thiols, disrupt-
ing transport in a similar way to other sulphydryl reagents [5,33].
Similar experiments were carried out with OGC vesicles that had
been preloaded with 5 mM malate to assess malate/[14C]-malate
homoexchange (Fig. 2C). Exchange of [14C]-malate for internal
malate occurred readily under these conditions and was blocked
by 2-oxoglutarate, while excess GSH again had no effect (Fig. 2C).
Competitor and inhibitor experiments of malate/[14C]-malate
homo-exchange also showed no effect of GSH (Fig. 2D). We con-
clude that excess GSH does not compete with the canonical OGC
transport process.
Transport of the canonical substrates by DIC was assessed by
preloading the fused membranes with 5 mM phosphate or malate,
followed by measurement of [14C]-malate uptake (Fig. 3A and C).
Heteroexchange of phosphate for [14C]-malate was quenched by
excess of the substrate succinate, whereas excess GSH had no
effect (Fig. 3A). Competitive inhibition was analysed further by
measuring the initial rates of transport in the presence of different
substrates and inhibitors of OGC (Fig. 3B). Heteroexchange rateswere decreased by excess of the substrate succinate and by the
known inhibitors butylmalonate and NEM, conﬁrming that the
DIC was working correctly (Fig. 3B). However, excess GSH or gluta-
mate had no effect on transport, indicating that these substrates
cannot compete effectively for transport. The small effect of GSSG
is most likely due to protein thiol modiﬁcation, as was found for
OGC. Malate/[14C]-malate homoexchange through the DIC was
established by loading the DIC-vesicles with 5 mM malate
(Fig. 3C). Homoexchange was again abolished by succinate, butyl-
malonate and NEM, but not by GSH, GSSG or glutamate (Fig. 3D).
Therefore, GSH is not a competitive substrate of the canonical
transport activity of DIC.
To investigate whether the small effect of GSSG on transport by
DIC and OGC was speciﬁc or non-speciﬁc, we explored the effect of
GSSG on the transport activity of two other mitochondrial carriers.
Addition of 10 mM GSSG affected the exchange of citrate/[14C]-cit-
rate by the mitochondrial citrate carrier (CiC) slightly (Fig. S2A),
but not the ADP/[14C]-ADP exchange catalysed by the mitochon-
drial ADP/ATP carrier (AAC) (Fig. S2B). As the OGC, DIC and CiC
L.M. Booty et al. / FEBS Letters 589 (2015) 621–628 627all have cysteine residues that could be modiﬁed by GSSG, whereas
the AAC does not, these ﬁndings are consistent with GSSG affecting
transport by non-speciﬁc thiol modiﬁcation, making it unlikely
that DIC or OGC are affected by GSSG through substrate competi-
tion. We conclude that GSH cannot compete with the canonical
substrates of OGC and DIC [34–36], even when present in
6700-fold excess.
3.3. Direct measurement of GSH transport
The above experiments showed that GSH does not compete with
transport of the canonical substrates of DIC or OGC. However, the
possibility remains that these carriers transport small amounts of
GSH. To assess this we measured direct transport of [35S]-GSH.
Fused membranes of the control strain did not have GSH/[35S]-
GSH exchange activity (Fig. 4A). When OGC vesicles were assessed
for GSH/[35S]-GSH exchange or 2-oxoglutarate/[35S]-GSH exchange,
there was also no measurable uptake. Similarly, no [35S]-GSH
uptake was found for DIC, whether the fused membranes were
pre-loaded with GSH for GSH/[35S]-GSH exchange, or with phos-
phate for phosphate/[35S]-GSH exchange (Fig. 4A). Finally, when
fused membranes expressing DIC and OGC were pre-loaded with
5 mM GSSG no uptake of [14C]-malate in exchange for GSSG could
be observed (Fig. 4A), even though the speciﬁc exchange of the
canonical substrates could bemeasured readily. These data indicate
that OGC and DIC are not involved in GSH transport.
3.4. Effect of pH on transport of GSH by DIC and OGC
The charge of GSH is pH-dependent due to the pKa of 8 of the
cysteine moiety and could be a factor in the transport of GSH by
DIC or OGC. Therefore, we carried out experiments at different
pH values (Fig. 4B). Vesicles containing DIC or OGC were preloaded
with 5 mM GSH and the initial rate of uptake of [35S]-GSH was
measured at pH 6, 7 or 8 (Fig. 4B). In none of these conditions could
uptake of GSH be observed, indicating that pH was not a relevant
factor.
4. Conclusions
The transport of GSH from the cytoplasm to mitochondria is
essential and had been suggested to be catalysed by the OGC
and DIC [12–19], but the transport process was poorly character-
ised. The identiﬁcation of the DIC and OGC as the mitochondrial
GSH transporter(s) was based on experiments in relatively com-
plex systems where the characterisation of the individual trans-
port processes was difﬁcult. In isolated kidney mitochondria
and mitoplasts [13,14] GSH uptake was inhibited by dicarboxyl-
ates and by inhibitors of the DIC and OGC [13,14]. However, many
other transport processes were also affected, and the DIC inhibi-
tor butylmalonate only affected transport in the presence of anti-
mycin A [14]. One study was carried out with puriﬁed OGC
reconstituted into liposomes following expression in E. coli
[16,37]. However, mitochondrial carriers expressed in E. coli can
only be reconstituted with relatively low yields and thus high
substrate gradients are required for their characterisation [38].
The transport of GSH by the reconstituted OGC did not have the
typical transport properties of mitochondrial carriers [37–42], as
transport ceased after two min [16]. Studies of the DIC and OGC
overexpressed within cells led to a number of interesting effects
[15,16,18], but these changes are likely to be secondary conse-
quences of metabolite redistribution between the mitochondria
and the cytosol, and cannot be taken as evidence for changes in
GSH transport. In contrast, the L. lactis system provides a
relatively simple and well established system to characterisemitochondrial carriers and other membrane proteins [28,29,32].
Using this approach we have shown that DIC and OGC do not
transport GSH and thus the mitochondrial GSH transporter still
needs to be identiﬁed.
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